latest update:
[RxAtlas]

drug summary · 2 NDC codes

WEGOVY 4 mg/1

semaglutide

HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status NDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.

dataset id 130414NDC codes 2application NDA218316RxCUI —

Facts

Field definitions, types, and provenance rules are in the data dictionary.

generic namesemaglutide
active ingredientsSEMAGLUTIDE
dosage formTABLET
routeORAL
strength4 mg/1
marketing statusNDA
DEA schedulenot reported
application numberNDA218316
ATC codenot reported
RxCUInot reported
manufacturerNovo Nordisk Pharmaceutical Industries, LP
product typeHUMAN PRESCRIPTION DRUG
pharmacologic classGLP-1 Receptor Agonist [EPC]; Glucagon-Like Peptide 1 [CS]; Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]

NDC codes

2 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.

NDCPackage description
00169440431—
0169-4404—

Other semaglutide products

19 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.

7 more are listed in the drug product index.

Work with this record

  • Field definitions

    Types, scope, and provenance rules for every exported field.

  • REST API

    Query the same gate-backed records programmatically.

  • Evaluation sample

    Download a bounded slice before buying.

  • $29 API Pass

    Seven days of REST and MCP access to the full catalogue; credited toward the licence.